Patents by Inventor Moritz LEPPKES

Moritz LEPPKES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11085922
    Abstract: A method for detecting and quantifying anti-neutrophil-cytoplasmic antibodies (ANCA) in a sample of bodily fluid from a patient suspected of suffering from an autoimmune disease, including the steps of contacting human polymorphonuclear neutrophils able to release extracellular traps (NETs) with microspheres to produce NET-coated microspheres, contacting the NET-coated microspheres with the sample of bodily fluid, and labeling and subsequent analyzing of anti-neutrophil-cytoplasmic antibodies by flow cytometric methods.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: August 10, 2021
    Assignee: Immundiagnostik AG
    Inventors: Franz Paul Armbruster, Moritz Leppkes
  • Publication number: 20190204311
    Abstract: The disclosure relates to a method for detecting and quantifying anti-neutrophil-cytoplasmic antibodies (ANCA) in a sample of bodily fluid from a patient suspected of suffering from an autoimmune disease, comprising the steps of contacting human polymorphonuclear neutrophils able to release extracellular traps (NETs) with microspheres, so that NET-coated microspheres are produced: contacting said NET-coated microspheres with said sample of bodily fluid suspected of containing anti-neutrophil-cytoplasmic antibodies; and labeling and subsequent analyzing of anti-neutrophil-cytoplasmic antibodies by flow cytometric methods.
    Type: Application
    Filed: December 13, 2018
    Publication date: July 4, 2019
    Inventors: Franz Paul ARMBRUSTER, Moritz LEPPKES